Teladoc Health (TDOC) Research & Development (2014 - 2026)

Teladoc Health has disclosed Research & Development across 13 years of filings, most recently posting $62.9 million for Q2 2026.

• In Q2 2026, Research & Development fell 8.61% year-over-year to $62.9 million; the TTM figure through Jun 2026 stood at $269.9 million (down 6.24% YoY), while the FY2025 annual figure was $277.9 million, down 9.55% from the prior year.
• Research & Development came in at $62.9 million for Q2 2026 at Teladoc Health, down from $67.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $89.9 million in Q4 2023 to a low of $62.9 million in Q2 2026.
• Average Research & Development over 5 years is $77.7 million, with a median of $77.7 million recorded in 2022.
• Year-over-year, Research & Development increased 13.81% in 2022 and dropped 14.66% in 2024.
• Over 5 years, Research & Development stood at $82.9 million in 2022, then grew by 8.45% to $89.9 million in 2023, then decreased by 14.66% to $76.8 million in 2024, then dropped by 6.7% to $71.6 million in 2025, then declined by 12.22% to $62.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $62.9 million in Q2 2026, $67.9 million in Q1 2026, and $71.6 million in Q4 2025.